XBIO Xenetic Biosciences Inc
Company Analysis
Latest News
🔴 Xenetic Biosciences is trading 5% down today
Xenetic Biosciences is trading 5.06% down now at $2.44, with no new company-specific announcement identified for September 23, 2026. - The latest major...
🔴 Xenetic Biosciences Inc is trading 10.37% down
XBIO is trading at $2.68, down 10.37%.
🔴 Xenetic Biosciences is trading 6% down today amid proposed Santersus acquisition uncertainty
Xenetic Biosciences is trading 6.02% down at $2.81 amid volatility surrounding its proposed all-stock acquisition of Santersus AG. - Santersus holders would...
🔴 Xenetic Biosciences is trading 7.36% down today in pre-market amid proposed Santersus acquisition volatility
Xenetic Biosciences is trading 7.36% down now at $2.77 in pre-market amid volatility around its proposed all-stock acquisition of Santersus AG. - Existing...
🟢 Xenetic Biosciences is trading 6.68% up today amid volatility around proposed Santersus acquisition
Xenetic Biosciences is trading at $2.96, up 6.68%, rebounding after volatility around the proposed Santersus acquisition. - It closed at $2.77 on September 18...
🔴 Xenetic Biosciences is trading 6.1% down in pre-market amid volatility following proposed Santersus acquisition
Xenetic Biosciences is trading $2.60 (-6.14%) amid volatility following the proposed all-stock Santersus acquisition, after closing at $2.77 on September 18. •...
🟢 Xenetic Biosciences is trading 11.4% up today following proposed all-stock Santersus acquisition
Xenetic Biosciences is trading 11.4% up at $2.74 amid continued volatility following its proposed all-stock acquisition of Santersus AG. - Santersus...
🟢 Xenetic Biosciences is trading 6.5% up today following proposed all-stock acquisition
Xenetic Biosciences is trading 6.5% up now at $2.62 amid continued volatility following its proposed all-stock acquisition of Santersus AG. - Santersus...
🔴 Xenetic Biosciences is trading 6.4% down today as Santersus shareholders would own 85%
Xenetic Biosciences is trading 6.4% down now at $2.30 as investors continue repricing the proposed all-stock acquisition of Santersus AG. - Under the...
🔴 Xenetic Biosciences is trading 6.1% down in pre-market over dilution concerns tied to proposed Santersus acquisition
Xenetic Biosciences is trading 6.1% down now at $2.31 as investors continue weighing the proposed all-stock acquisition of Santersus AG. - Santersus...
🟢 Xenetic Biosciences is trading 8.5% up today in pre-market amid stronger overnight equity sentiment
Xenetic Biosciences is trading 8.54% up at $2.67, with the rebound broadly supported by stronger overnight equity sentiment after closing September 17, 2026,...
🔴 Xenetic Biosciences is trading 5.49% down in after-hours trading with no identified company announcement
Xenetic Biosciences is trading 5.49% down at $2.33 after no separate company announcement dated September 17 was identified to explain the after-hours...
🟢 Xenetic Biosciences is trading 11% up today as biotech shares rally
Xenetic Biosciences is trading 11.03% up now at $2.43 as biotechnology shares rally alongside broader risk-on markets. - The sector’s advance reflects...
🟢 Xenetic Biosciences rises 5.9% — Biotech Sector Rallies on Strong Industry Outlook and M&A Optimism
With Biotech (XBI) up 2.5%, this looks like a sector-led move rather than a company-specific surprise. The biotechnology sector, as measured by the XBI ETF,...
🔴 Xenetic Biosciences is trading 5.94% down in pre-market over dilution concerns from proposed Santersus deal
Xenetic Biosciences is trading 5.94% down at $2.06 after its September 16, 2026 announcement of a proposed all-stock acquisition of Santersus AG. - Existing...
🔴 Xenetic Biosciences is trading 38.76% down today after announcing proposed all-stock acquisition of Santersus AG
Xenetic Biosciences is trading $2.62 (-38.76%) after announcing a proposed all-stock acquisition of Santersus AG. - The transaction was announced on September...
XBIO Hands 85% of Itself to a Swiss Blood-Cleaning Startup — Is the Remaining Sliver Worth the Gamble?
Shares of Xenetic Biosciences (XBIO) cratered 22% to $3.32 on September 16 after the micro-cap biotech disclosed a reverse merger with Santersus AG, a private...
🔴 Xenetic Biosciences is trading 22.17% down in pre-market after announcing all-stock reverse merger with Santersus AG
Xenetic Biosciences is trading at $3.32, down 22.17%, in pre-market after announcing an all-stock reverse merger with Santersus AG on September 16, 2026. •...
Xenetic Biosciences to Acquire Santersus AG in All-Stock Reverse Merger Transaction
Xenetic Biosciences, Inc. (XBIO) has entered into a Share Exchange Agreement to acquire Santersus AG, a Swiss corporation. The all-stock transaction will...
🔴 Xenetic Biosciences falls 5.6% — Biotech Sector Declines on Key Drug Trial Failure and Shifting Investor Sentiment
With Biotech (XBI) down 2.1%, this looks like a sector-led move rather than a company-specific surprise. The biotech sector, as measured by the XBI ETF, fell...